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Abstract
Background: The VL elimination strategy requires cost-effective tools for case detection and management. This intervention
study tests the yield, feasibility and cost of 4 different active case detection (ACD) strategies (camp, index case, incentive
and blanket approach) in VL endemic districts of India, Nepal and Bangladesh.
Methodology/Principal Findings: First, VL screening (fever more than 14 days, splenomegaly, rK39 test) was performed in
camps. This was followed by house to house screening (blanket approach). An analysis of secondary VL cases in the
neighborhood of index cases was simulated (index case approach). A second screening round was repeated 4–6 months
later. In another sub-district in India and Nepal, health workers received incentives for detecting new VL cases over a 4
month period (incentive approach). This was followed by house screening for undetected cases. A total of 28 new VL cases
were identified by blanket approach in the 1st screening round, and used as ACD gold standard. Of these, the camp
approach identified 22 (sensitivity 78.6%), index case approach identified 12 (sensitivity – 42.9%), and incentive approach
identified 23 new VL cases out of 29 cases detected by the house screening (sensitivity – 79.3%). The effort required to
detect a new VL case varied (blanket approach – 1092 households, incentive approach – 978 households; index case
approach – 788 households had to be screened). The cost per new case detected varied (camp approach $21 – $661; index
case approach $149 – $200; incentive based approach $50 – $543; blanket screening $112 – $629). The 2nd screening round
yielded 20 new VL cases. Sixty and nine new PKDL cases were detected in the first and second round respectively.
Conclusions/Significance: ACD in the VL elimination campaign has a high yield of new cases at programme costs which
vary according to the screening method chosen. Countries need the right mix of approaches according to the
epidemiological profile, affordability and organizational feasibility.
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Introduction
India, Nepal and Bangladesh have committed to eliminate VL
by 2015 and have adopted multiple public health strategies
towards the elimination goal of reducing VL cases to less than 1
per 10,000 population [1]. Treatment with Miltefosine, the first
oral effective drug, the possibility of an effective safe and affordable
single dose liposomal amphotericin for treatment, the high
specificity of rk39 rapid diagnostic test, and the absence of an
animal host reservoir, makes VL a potential target disease for
elimination [2–4].
VL control program strategies aim to reduce morbidity and
mortality and involve a number of approaches. These include early
diagnosis and prompt treatment of VL cases, surveillance for early
detection of VL outbreaks, making available appropriate diagnostic
facilities and drugs, promotion of health awareness, clinical and
epidemiological research, and implementation of integrated vector
management strategies including indoor residual spraying, use of bed-
nets and improvement of environmental and housing conditions.
However, despite these efforts, VL transmission continues
primarily in the absence of an effective surveillance system.
Though VL patients ultimately report to health centers and
hospitals, diagnosis is often missed in the early stages of infection
and delayed due to lack of diagnostic facilities at peripheral levels
of health systems with a consequent delay in treatment and
sustaining the human reservoir [5], [6].
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Shortage and supply delays of VL drugs, unavailability of
diagnostics at the health center level often contributes to the
community’s poor public perception of the public health systems, a
loss of faith and consequent low community participation/
involvement in VL control program activities [7]. A passive
surveillance for VL in the public sector is further hampered by an
un-regulated private sector which fails to notify VL disease even
where required by regulation.
This paper analyzes the feasibility, new case yield and costs of
different active case detection strategies as applied in different country
VL control program contexts at different VL endemicity levels.
Materials and Methods
Ethics Statement
The research program was approved by the Ethics Committees
of all participating sites (Ethics Committee, Rajendra Memorial
Research Institute of Medical Sciences; Ethics Committee,
Institute of Medical Sciences, Banaras Hindu University; Institu-
tional Review Board, Institute of Medicine, Tribhuvan University;
Ethics Review Committee, ICDDR,B, and Ethics Review
Committee, World Health Organization). Subjects participated
in the study after a written informed consent.
Study design
The study was designed to test 4 different ACD strategies –
camp, index case and blanket ACD strategies (see below)
implemented serially in one health center area; and incentives
based ACD strategy implemented in parallel in a geographically
discontinuous health center area. The study was conducted from
May to December 2009.
Study area profile
The study was conducted in the highly VL endemic districts of
Saran and Muzaffarpur in Bihar in India, Sarlahi district of Nepal
and Mymensingh district of Bangladesh. These regions were
selected for their reported high annual VL incidence (per 10,000
population) varying from 20 – 25 in India, 5 – 8 in Nepal and 13 –
31 in Bangladesh. VL control strategies have been implemented
variably in all the study districts. Indoor residual spraying has been
sporadic and more focal in ‘hot spots’ both in the districts of India
and Nepal but has not been done in Bangladesh. Miltefosine and
amphotericin B was available in the study districts of India and
Nepal but not yet in Bangladesh where at the time of the study,
antimonials continued to be the mainstay of VL treatment. VL
surveillance relied entirely on passive reporting.
Active Case Detection strategies
The following 4 different ACD strategies were tested for early
identification of VL cases in India, Nepal and Bangladesh:
Camp approach (Mobile teams visiting target villages)
A camp schedule was developed by the researchers in
consultation with District and Health Center Officials. Commu-
nity sensitization meetings were conducted through village health
workers at the village level to solicit involvement of village elders
and leaders in the organization of the camps. The Health Center
Medical Officer was invited to conduct/assist in the camp.
Anganwadi workers, Accredited Social Health Activists (ASHAs in
India), health workers and other governmental and non-govern-
mental village level functionaries were assigned roles for
promotion and conduct of the camps. Public announcements
using loudspeakers were used one day before and on the day of the
camp for ensuring publicity for the camps. During the camp, all
attendees were screened for fever more than 14 days and
examined for splenomegaly. Patients with a positive rK39 test
were referred to the nearest health center for treatment with
subsequent follow up at home. Additionally, patients with a history
of VL treatment in the past and suspected PKDL-like skin lesions
were tested with rK39 RDT and referred for confirmation of
diagnosis and treatment. The duration of camps was between half
to one day; in Nepal, due to the long travel distances, 3 camps in
different villages were held back to back while in India and
Bangladesh the camp staff returned to their base over night.
Blanket approach (house to house screening)
House to house screening was used as a gold standard to assess
how many new VL cases were missed by the camp approach. This
was done including all households of the target villages the day
following the camp. All households were numbered and members
were screened by trained field staff for fever more than 14 days
using a short screening questionnaire which also contained
questions on VL disease which had occurred during the 12
months preceding the interview. Persons with chronic fever were
examined for spleen enlargement by a physician/trained techni-
cian, and if positive were tested with rK39 and then sent for
treatment to the closest health centre. Similarly, individuals with a
past history of VL treatment with PKDL-like lesions were either
referred to the health center or tested with rK39 test and if positive
referred for confirmation of PKDL diagnosis and treatment.
Index case based approach (search for new cases in the
neighborhood of known cases)
To avoid a repeat survey in the same village following the
blanket approach, the index case approach was simulated. A list of
known VL patients in the target villages of the study treated in the
past or currently on treatment was obtained from the health center
records. These patients (defined in our study as ‘index’ case) were
traced in the village and then visited in reality at their house where
their presence was confirmed. All household identity numbers
Author Summary
For the elimination of any infectious disease (i.e., reduction
of the burden of a serious public health problem to a
minor problem which can be managed by the general
health services) the right mix of public health tools has to
be identified for the early detection and successful
treatment of new cases as well as effective vector control
(in the case of vector borne diseases) at affordable costs.
The paper provides a powerful example of evidence
building for cost-effective early case detection in the
visceral leishmaniasis elimination initiative of Bangladesh,
India and Nepal. It compares the camp approach (mobile
teams testing in chronic fever camps for spleen enlarge-
ment and rapid diagnostic tests) with the index case
approach (screening for new cases in the neighbourhood
of reported visceral leishmaniasis patients) and the
incentive based approach (where basic health workers
receive an allowance for detecting a new case) using
subsequent house-to-house screening for the identifica-
tion of the real number of un-detected cases. By applying a
mix of different study methods and an itinerate research
process to identify the most effective, feasible and
affordable case detection method, under different envi-
ronmental conditions, recommendations could be devel-
oped which help governments in shaping their visceral
leishmaniasis elimination strategy.
Case Detection Strategies for VL
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within 50 m radius or up to 100 households around the ‘index’
case were listed. This household list was then compared with the
households screened in the blanket approach. Any individual from
this household list, who had been detected by the house to house
screening as a new VL case, was considered a new VL case
detected by the index case approach.
Incentives based approach (case detection by village
health workers who received an incentive as additional
motivation for detecting new VL cases)
This approach was implemented in India and Nepal (not in
Bangladesh for political reasons) during a 4-month period in a well
defined geographically distinct health center area. Health workers,
Anganwadi workers, ASHA workers and community health
volunteers were trained in the early identification and referral of
suspected VL and PKDL cases in the community. Visual screening
aids including photographs of PKDL cases were used for identifying
patients for referral on an ongoing basis. An innovative incentive
structure was developed in consultation with district health officials.
Incentives (about USD 6) were paid for each new VL/PKDL case
detected. All confirmed cases of VL/PKDL identified through this
approach were ascertained by the researchers. After 4 months of
incentive based ACD, a blanket house to house survey was
conducted to ascertain the remaining VL/PKDL cases in the
community not detected by the incentive based approach.
Timeline and sequence of sub-studies
In order to assess the need for repeated camps in the same
endemic villages, the camp approach with subsequent house to
house screening was repeated 4 to 6 months after the first round in
order to measure the yield of new cases after a certain period of time.
Definitions and treatment strategies
The WHO definition of suspected VL (fever .14 days with
splenomegaly in a VL endemic area and a positive rK39) was
taken as basis for initiating treatment as indicated in the national
treatment guidelines of the three countries. Patients with PKDL
like skin lesions with a past history of VL treatment and testing
positive for rK39 were treated for PKDL.
Outcome measures and sample size
The different ACD strategies were evaluated for their sensitivity
of detecting new VL cases using the blanket approach as the
reference. Assuming a VL incidence of about 12 per 10,000
population, a total of about 48 newly diagnosed VL cases are
expected to be detected per study site which requires a screening
population of 40,000 individuals per site. This sample will detect
an average sensitivity of 80% with 8% absolute precision at a.05
significance level. On the basis of this assessment, it was decided to
screen a population of approximately 40,000 people per site.
Cost analysis
In order to calculate the costs of different forms of active case
detection for the control program, only those direct costs were
included in our assessment which would have to be paid from the
budget of the governmental VL control program. The following
cost elements were assessed: training, local travel and costs for
preparation, costs for materials and allowance costs for personnel
involved in the approach.
Data management and analysis
Data was entered in Epi Info at each site, preliminary cleaning
was done before transferring the data base to the data
management centre in Pune, India. A second check was
performed and a joint data base was created. The data analysis
was done using STATA.
Results
Background characteristics
The study was carried out in known VL endemic districts
(annual incidence varying from 5 per 10,000 in Nepal to 30 per
10,000 in India and Bangladesh). The population in the study
districts was poor and less educated compared to the national
average. The age and sex composition of the study population
across all sites was similar showing a relatively young population.
ACD strategies for VL case detection
Camp approach. A total of 61 and 52 VL/PKDL screening
camps were held in the 1st and 2nd round of ACD respectively.
Overall, camps were more successful in screening for VL in
Bangladesh and Nepal (average number of patients with fever for
more than 14 days, detected at the camps 11.8 and 13.8
respectively) while camp screening outcome was lower at the
Indian sites (average 9.7 chronic fever patients per camp). Out of a
total of 345 chronic fever cases identified in the 1st round, 22 had
spleen enlargement and tested positive with rK39 test (3 in
Muzarfurpur and 5 in Saran, India, 5 in Nepal and 9 in
Bangladesh) (table 1). The percentage of chronic fever cases testing
positive for VL was 6.4% with 3.4% and 11.1% in camps in India,
6.2% in Nepal and 6.8% in Bangladesh in the 1st round of
intervention.
Blanket approach. Following the screening camps, all
households in the same villages were screened by house to house
visits. A total of 165850 individuals were screened for VL/PKDL
in the 1st round of the blanket household survey. Overall, out of a
total of 549 chronic fever patients, an additional 6 new hitherto
undiagnosed patients had spleen enlargement and tested positive
with the rK39 test with 1 new VL case in Saran, India and 5 new
cases in Bangladesh. No new VL cases were detected in the
blanket household survey additional to those already detected in
the screening camps in Muzaffarpur, India and Sarlahi, Nepal
(table 1). The percentage of chronic fever cases testing positive for
VL in the blanket household survey was 10% and 1.9% in India,
6.2% in Nepal and 5.5% in Bangladesh in the 1st round.
Index case based approach. Overall, a total of 236 index
cases (VL cases reported by PHC in the past 1 year) were
identified in the study areas. A simulation exercise of a focal search
of households within 50 m radius of the index cases yielded a total
of 12 new cases of hitherto undiagnosed VL (table 1).
Incentive based approach. The incentive approach was
applied only in the Indian and Nepal sites in a separate PHC/
Union area. Basic health workers/volunteers identified over a
period of 6 months, a total of 23 hitherto undiagnosed new VL
cases out of a total of 29 new VL cases, the 6 additional cases being
detected in the same communities through a cross sectional house
to house screening at the end of the period (table 1).
Sensitivity of different strategies for active VL case
detection
Sensitivity for the camp, index and incentive approach was
calculated separately as percentage of new VL cases identified by
each of the approaches divided by the new VL cases identified by
the ‘gold standard’ blanket approach. Overall, in the 1st round, the
camp approach detected 78.6% of all new VL cases in the study
villages: 64.3% in Bangladesh, 83.3% in Saran, India but 100% in
Muzaffarpur, India and Sarlahi, Nepal (table 2).
Case Detection Strategies for VL
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The index case approach detected less than half (42.9%) of new
VL cases detected by the blanket approach (35.7% in Bangladesh,
66.7% in Saran, India) which covered a larger area than the 50
meter around index case houses. No new VL cases were detected in
households situated within 50 m radius of any of the 19 index cases
identified in Nepal (table 2) in contrast to Muzaffarpur in India
where the index case approach was able to detect all the 3 new VL
cases identified by the blanket approach in the community.
Overall, the incentive approach was able to detect 79.3% of
new VL cases in the community (66.7% and 78.9% in the Indian
sites and 100% in Nepal; table 2).
Periodicity of ACD strategies
The 2nd round of screening was implemented 4–6 months after
the 1st round. The yield of new cases detected through the camp
approach was, with the exception of Saran, India, in all study sites
lower in the 2nd round as compared to the 1st round (average
number of patients detected with fever more than 14 days ranged
from 1.6 and 3.5 patients per camp in India to 7.5 in Nepal and
4.6 patients in Bangladesh). The percent increase of VL cases by
adding ACD to PCD was lower in the 2nd round (see below).
Overall, out of a total of 196 fever cases detected, only 12 hitherto
undiagnosed VL patients were identified which is 6.1% of the
chronic fever cases.
Similarly, in the blanket approach of round 2, out of a total of
409 chronic fever cases, 20 hitherto undiagnosed VL cases were
detected (4.9%; table 1).
A total of 20 new VL cases were identified in the 2nd screening
round (India 8 in Saran and 2 in Muzaffarpur; Nepal – 3; and
Bangladesh – 7) compared to 28 new VL cases in the 1st round.
Regarding the sensitivity of different ACD approaches, there was a
non-significant decrease from the first to the second round (table 2);
the sensitivity of the camp approach was 60% and of the index
case approach 20%.
Table 1. Case yield by different ACD strategies.
Round 1 Round 2 (4 to 6 months after 1st round)
Saran
India
M’pur
India
Sarlahi
Nepal
M’Singh
B’desh Overall
Saran
India
M’pur
India
Sarlahi
Nepal
M’Singh
B’desh Overall
Camp approach
No. of Camps held 19 21 6 15 61 18 14 6 14 52
Average # of camp attendees 301 87 83 178 649 351 23 63 77 514
Old VL cases1 (,1 yr) detected 5 2 3 9 19 1 0 21 0 22
Fever cases (.14 days) screened 45 87 80 133 345 64 23 45 64 196
New VL cases2 detected (rK39 +ve) 5 3 5 9 22 5 2 3 2 12
Old PKDL cases (,1 yr) detected 1 0 0 1 2 0 0 0 0 0
Suspected Skin lesions screened 0 0 3 50 53 0 0 0 7 7
New PKDL cases detected 0 0 0 42 42 0 0 0 3 3
Blanket approach
Total population screened 47908 42761 35081 40100 165850 48461 43565 33744 40065 165835
Old VL cases (,1 yr) detected 127 113 96 80 416 32 23 4 74 133
Fever cases (.14 days) 60 157 80 252 549 82 95 71 161 409
New VL cases3 detected (rK39 +ve) 6 3 5 14 28 8 2 3 7 20
Old PKDL cases4 (,1 yr) detected 8 3 0 13 24 0 4 1 17 22
Suspected Skin lesions screened 4 7 0 84 95 2 5 6 23 36
New PKDL cases detected 0 5 0 60 65 0 2 0 7 9
Index case based approach
# old VL index cases reported by PHC 80 58 19 79 236 30 16 5 87 138
New VL cases detected in focal search around
index case (rK39 +ve)
4 3 0 5 12 0 1 0 3 4
New PKDL cases detected in focal search 0 0 0 15 15 0 0 0 0 0
Incentive based approach (over 4 months)
New VL cases detected by incentives 15 4 4 23
Total population screened in incentive approach
study area (HH survey)
42874 44090 34015 120979
Old VL cases (1 yr) detected in HH screening in incentive area 19 6 4 29
New VL cases5 (rK39 +ve) detected in HH screening in
incentive area
19 6 4 29
1Old case defined as case detected by passive case detection/routine surveillance but not necessarily notified.
2New case defined as fever more than 14 days + splenomegaly + rK39 test positive.
3New cases detected by blanket approach includes the new cases detected by the preceding camp approach.
4Old cases detected by blanket approach includes the old cases detected by the preceding camp approach.
5New VL cases detected in household survey includes the new VL cases detected by the incentive based approach.
doi:10.1371/journal.pntd.0000960.t001
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VL disease burden in the study areas
The VL disease burden, estimated as the annual VL incidence
by adding the ‘‘old’’ cases, which have been detected by PCD
during the preceding 12 months and ‘‘new’’ cases detected by the
blanket approach (which includes the case detected by camps) was
similar across all sites: 23.4 per 10,000 in Bangladesh; 27.1 and
27.8 in the Indian sites and 28.8 per 10 000 in Nepal (which was
due to a VL outbreak in one of the study villages with 96 cases in
the preceding year). The percent increase of VL cases (i.e. ACD
cases (x100)/PCD cases) was substantial with a 115% overall
increase of case numbers (22x100/19) when adding ACD to PCD.
In the second round the percent increase was less with 54.5%
(126100/22).
PKDL detection
In the 1st round, a total of 42 new PKDL cases (all from
Bangladesh) were detected by the camp approach and 23
additional new PKDL cases (Bangladesh – 18; Muzaffarpur,
India – 5) in the subsequent blanket household screening.
Interestingly, the index case approach was able to detect 15 of
these new PKDL cases in the focal search around any of the VL
index cases. The incentive based approach (not done in
Bangladesh) did not yield any new PKDL case. A total of 9 new
PKDL cases (Muzaffarpur, India – 2; Bangladesh – 7) were
detected in the 2nd round using the blanket approach. The Nepal
and the Saran, India site did not detect any new PKDL case
during both rounds.
The point prevalence of PKDL (known + new PKDL cases
based on the blanket approach) is estimated to be about 1.9 and
18.2 per 10,000 in India and Bangladesh respectively.
The camp approach in Bangladesh was able to detect 70% (42/
60) of all new PKDL cases in the community compared to the
blanket approach in the 1st round and 42.9% (3/7) in the 2nd round.
Effort and costs of ACD
In the 1st round, the effort to detect a new VL case through the
camp approach was highest in India (0.14 and 0.26 new VL cases
detected per camp) compared to 0.60 and 0.83 cases per camp in
Bangladesh and Nepal respectively.
In the index case approach the search in the neighborhood of
an index case yielded about 0.05 to 0.06 new VL cases per focal
search in India and Bangladesh respectively. Estimates for Nepal
could not be determined as there were no new cases detected
through the index case approach.
The number of households to be screened to detect one new VL
case was higher for the blanket approach (1092 households per 1
new VL case; range 654 to 2433 households (non-incentive
approach area) and 978 households, range 594 to 1888
households, in the incentive approach areas) than for the
geographically restricted index approach areas where 648
households (range 174 to 1000 households) would have to be
screened for detecting one new VL case (table 3).
The average cost (including costs for training, preparation and
conduct) for a camp in the 1st round, ranged from USD 85.8 in
Muzaffarpur, India to USD 195 in Nepal (table 4). The cost for
detecting a new VL case by the camp approach ranged from USD
21.72 in Muzaffarpur, India to USD 661 in Saran, India. The
estimated cost for detecting a new VL case by the index case
approach (using cost simulations, see methods) ranged from about
USD 149.10 in Bangladesh to about USD 200 in the Indian sites.
The cost for detecting a new VL case by the incentive based
approach ranged from USD 50 and 95 in India to USD 543.25 in
Nepal. Similarly, the cost for detecting a new VL case by the
blanket approach ranged from USD 112 in Muzaffarpur, India to
USD 629 in Nepal.
Discussion
Although we did not take a representative sample of our study
populations, it became clear that the annual VL incidence in
endemic districts in India and Bangladesh continues to be very
high – more than 20 times the elimination target of 1 per 10,000 to
be achieved by 2015 and in the range of previous studies [8], [9].
The burden of VL disease is grossly underestimated [10], [11] by
the health systems in the Indian sub-continent due to over-
Table 2. Sensitivity (95% CI) of camp, index and incentive approach with reference to blanket approach for detecting VL and/or
PKDL cases.
Round 1 Round 2
Saran India M’pur India
Sarlahi
Nepal M’sinh B’desh Overall Saran India M’pur India
Sarlahi
Nepal
M’sinh
B’desh Overall
Camp
VL
(95% CI)
83.3% (5/6)
(35.8–99.5)
100% (3/3)
(29.2–100)
100% (5/5)
(47.8–100)
64.3% (9/14)
(35.1–87.2)
78.6% (22/28)
(59.0–91.7)
62.5% (5/8)
(24.4–91.4)
100% (2/2)
(15.8–100)
100% (3/3)
(29.2–100)
28.6% (2/7)
(3.6–70.9)
60% (12/20)
(36.0–80.8)
PKDL
(95% CI)
--- 0% (0/5)
(0–52.2)
--- 70.0% (42/60)
(56.7–81.1)
64.6% (42/65)
(51.7–76.1)
--- 0% (0/2)
(0–84.1)
--- 42.9% (3/7)
(9.8–81.5)
33.3% (3/9)
(7.4–70.0)
Index
VL
(95% CI)
66.7% (4/6)
(22.2–95.6)
100% (3/3)
(29.2–100)
0% (0/5)
(0–52.1)
35.7% (5/14)
(12.7–64.8)
42.9% (12/28)
(24.4–62.8)
0% (0/8)
(0–36.9)
50% (1/2)
(1.2–98.7)
0% (0/3)
(0–70.7)
42.9% (3/7)
(9.8–81.5)
20% (4/20)
(5.7–43.6)
PKDL
(95% CI)
--- 0% (0/5)
(0–52.2)
--- 25.0% (15/60)
(14.7–35.8)
23.1% (15/65)
(13.5–35.2)
--- 0% (0/2)
(0–84.1)
--- 0% (0/7)
(0–40.9)
0% (0/9)
(0–33.6)
Incentive
VL
(95% CI)
78.9% (15/19)
(54.4–93.9)
66.7% (4/6)
(22.2–95.6)
100% (4/4)
(39.7–100)
NA 79.3% (23/29)
(60.2–92.0)
NA NA NA NA NA
PKDL
(95% CI)
--- --- --- ---
doi:10.1371/journal.pntd.0000960.t002
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Table 3. Efforts required for different ACD strategies.
Round 1 Round 2
Saran
India
M’pur
India
Sarlahi
Nepal
M’sinh
B’desh Overall
Saran
India
M’pur
India
Sarlahi
Nepal
M’sinh
B’desh Overall
Mean # of new VL cases detected per camp 0.26 0.14 0.83 0.6 0.36 0.28 0.14 0.50 0.14 0.23
Mean # of new VL cases detected per index case 0.05 0.05 --- 0.06 0.05 --- 0.06 --- 0.03 0.03
# households screened to detect a new VL case
Index case based approach 1000 967 --- 174 648 --- 800 --- 249 387
Incentive based approach 594 1888 1511 NA 978 NA NA NA NA NA
Blanket approach 1326 2433 1234 654 1092 991 3672 1991 1305 1519
doi:10.1371/journal.pntd.0000960.t003
Table 4. Direct costs of different ACD strategies.
Round 1 Round 2
Saran
India
M’pur
India
Sarlahi
Nepal
M’sinh
B’desh Overall
Saran
India
M’pur
India
Sarlahi
Nepal
M’sinh
B’desh Overall
Camp approach
Training cost 267 81.33 114 288.32 187.66 267 88.89 96.66 58.69 127.81
Travel, Preparation cost 2026 669.11 184 465.46 836.14 1982 595.56 168 394.74 785.07
Allowance cost for camp 1014 786.67 836 422.34 764.75 961 733.33 886.67 398.25 744.81
Materials cost 0 265.69 36 426.16 181.96 0 89.29 36 35.77 40.26
Total (camp approach) 3307 1802.80 1170 1602.30 1970.53 3210 1507.07 1187.33 887.50 1697.98
Index case approach
Training cost 93 0 14.60 35.86 93 --- --- 11.68 52.34
Travel, Preparation cost 333 176 353.77 287.59 333 --- --- 311.60 322.30
Allowance cost for screening 374 384 287.30 348.43 374 --- --- 287.30 330.65
Materials cost 0 2.67 89.60 30.75 0 --- --- 26.32 13.16
Total (index case approach) 800 5721 562.65 745.53 702.72 800 3091 ---2 636.90 718.45
Incentive based approach
Training cost 511 181 793.33 495.11
Travel, Preparation cost 0 0 113.33 37.77
Allowance cost for screening 233 164 1032 476.33
Materials cost 0 35 234.67 89.89
Total (incentive based approach) 744 380 2173.33 NA 1099.11
Blanket approach
Training cost 889 38 188 52.41 291.85 889 90.67 180 0 289.91
Travel, Preparation cost 1422 1776 97 1057.10 1088.03 1422 1866.67 95 219.71 900.84
Allowance cost for screening 933 7200 2834 1328.76 3073.94 933 2411.11 2926 646.42 1729.13
Materials cost 0 267 26 749.20 260.55 0 288.89 30 586.20 226.27
Total (blanket approach) 3244 9281 3145 3187.40 4714.35 3244 4657.33 3231 1452.33 3146.17
Cost per new VL case detected (USD)
Camp approach 661 21.72 234 178.03 273.68 642 22.83 395.78 443.75 376.09
Index case based approach 200 191 --- 149.10 180.03 --- --- --- 212.30 212.30
Incentive based approach 50 95 543.25 NA 229.41 NA NA NA NA NA
Blanket approach 541 112 629 227.67 377.41 405 202.49 1077 207.47 472.99
Cost per camp (USD) 174 85.8 195 106.8 129.2 178.3 107.6 197.8 63.4 130.6
1Detailed costs break up for Index case approach for Muzaffarpur, India not available.
2Costs for Index case based approach for Nepal has been estimated over the entire study period and not by round.
doi:10.1371/journal.pntd.0000960.t004
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reliability on passive surveillance. Active case detection strategies
(household screening and index case based screening) were shown
to provide a more realistic representation of the VL burden and
are able to improve early diagnosis and potentially treatment of
VL [12].This has been reconfirmed in our study where the
increase of VL cases by adding ACD to PCD was more than
double in the first screening round.
In the present study we could show that the blanket approach of
household screening for VL yielded the highest number of new
cases, though this ‘gold standard’ for active case detection was
expensive and will be difficult to sustain by health systems.
Moreover, the effort to conduct the blanket approach is much
higher in terms of training manpower for the screening and
supervision to ensure the quality of screening and subsequent actions
such as spleen examination and Rapid Diagnostic Tests (RDTs).
The camp approach has been extensively used in public health
care such as in pulse polio immunization, vitamin A prophylaxis and
other public health interventions. This strategy is being tested for
the first time in the context of disease surveillance for early diagnosis
and treatment of VL. The camp approach, though largely
standardized in our study, was implemented with some local
variation in India, Nepal and Bangladesh and was successful in
detecting three quarter of the unrecognized VL burden in the
community. Only approximately 5% of patients with chronic fever
had VL and this is a similar proportion of patients with chronic
cough that have tuberculosis [13]. This means that it is cost-effective
to have trained health staff in the team who can complete the VL
diagnosis by doing spleen examination and the RDT. Although we
did not compare different delivery mechanisms of chronic fever
camps, it can be assumed that camp attendance can be improved by
better pre-camp preparation to overcome an indifferent attitude of
grass-root level village health workers and negative community
attitudes towards public health interventions. The sensitivity of the
fever camps for identifying new cases, although of acceptable levels
in our study, may also be improved by using better communication
skills to increase the demand of camp services. The costs of the camp
approach were reasonable in our study. However, areas for savings
can possibly be identified. Additional preparatory and planning
efforts could also increment program costs.
The index case approach as conducted in our study limited the
search for new cases to a 50 m radius around the houses of an index
case. This is based on the study by Bern et al [14] who found the
proximity to a previous VL case to be a high risk factor for a new
infection and on unpublished data by Mondal et al. (personal
communication) who found a sharp decrease of VL seroprevalence
from Index case houses beyond a radius of 50 m.However, as long as
we do not have reliable information on the flight range of vectors and
the role of subclinical VL cases in the transmission dynamics, we will
not be able to provide clear guidance for where and when to search
for secondary cases around an index case. In our study the index case
approach was able to identify less than half the VL burden in the
community. This was mainly due to the fact that the other newly
detected VL cases by house to house screening were living beyond
the 50 m radius limit indicating the need for extending the search
area in the index case approach of a public health program. A special
case was Nepal where in one village, due to an earlier VL outbreak,
many index cases were located and extensive case tracing had been
done previously, so that no new cases could be detected. Though the
pattern is not definitive, it appears that the index case approach
performs reasonably well in moderate (Bangladesh) to high (India)
VL endemic areas but further research is required for confirmation.
The estimated costs of the index case approach were comparatively
low though the approach needs to be modified to include
geographical areas beyond the 50 m radius around index case
houses. It will also be necessary to establish whether the chronic fever
patient has to be sent to the health services for further assessment or
can receive a full diagnosis, including spleen examination and RDT
by a skilled health worker in the home village.
The incentive based approach was able to detect 80% of the VL
burden in the community, the highest (100%) being in Nepal
where the VL endemicity is relatively low [5]. Though not
definitive, this suggests that the incentive based approach works
well in low VL endemic areas. Incentives have been tried
extensively in public health to improve utilization of services such
as contraception, tuberculosis treatment and others. India has
recently introduced performance based incentives into their health
systems to achieve health care targets. The costs of incentive based
approach for VL disease surveillance was lowest (except in Nepal)
in our study yet effective in low disease burden settings. Most
economic burden studies have focused on costs of VL patient
management [15–17] and not on case detection. Further research
is needed to assess cost effectiveness of the full VL elimination
program strategies.
The study also provides insights into the periodicity with which
active case detection should be applied. The second ACD rounds
for camp and index case approaches showed a much lower
percent increase of newly detected VL cases compared to the 1st
round and likewise the number of VL cases detected per camp
decrease from 0.36 (1st round) to 0.23 (2nd round). Likewise in the
index case approach the number of new cases per index case was
1.66 times higher in the 1st round (0.05 new VL cases per index
case) than in the 2nd round (0.03 new VL cases per index case).
On the other hand, the number of newly detected cases in the
second screening round by the camp approach was still
substantial, so that affordability and staff availability will be
important for the decision if ACD through camps should be done
during the current VL elimination campaign once or twice per
year in the same villages. Further research on different ACD
delivery mechanisms and their costs can provide additional
support for rational decision making.
The study provided further evidence on the huge burden of
PKDL disease in the community especially in Bangladesh [18] and
the ability of ACD to shed light on this largely unrecognized health
problem. Further research is needed to better understand the low
PKDL prevalence in India and Nepal and to determine cost
effective treatment interventions.
In conclusion, the study provides evidence on the effectiveness
and costs of different active case detection strategies. Preliminary
evidence suggests use of the camp approach in high VL endemic
settings, index case surveillance in high to moderate VL endemic
settings and incentive based surveillance in low VL endemic
settings. The study findings are useful for Country VL
Elimination Programs to choose the most appropriate ACD
method or tool mix for their communities, depending on the
level of VL endemicity, feasibility of implementing these
strategies and affordability within the context of their health
systems.
Supporting Information
STROBE checklist
Found at: doi:10.1371/journal.pntd.0000960.s00 (0.09 MB
DOC)
Acknowledgments
The authors are grateful to all Country, State and District VL Control
Program Managers for guiding the development of the research
Case Detection Strategies for VL
www.plosntds.org 7 February 2011 | Volume 5 | Issue 2 | e960
1
program. We also thank all our patients who consented to participate in
the study.
Author Contributions
Conceived and designed the experiments: SPS SH MMH MRB NK DM
SS PD CKG SR CPT BV AK. Performed the experiments: SPS SH
MMH MRB NK DM SS PD CKG SR CPT BV AK. Analyzed the data:
SPS SH MMH MRB NK DM SS PD CKG SR CPT BV AK.
Contributed reagents/materials/analysis tools: SPS SH MMH MRB NK
DM SS PD CKG SR CPT BV AK. Wrote the paper: SPS SH MMH
MRB NK DM SS PD CKG SR CPT BV AK.
References
1. World Health Organization (2005) Regional strategic framework for elimination
of kala-azar from the South-East Asia region (2005-15). New Delhi: WHO
regional office for South-East Asia.
2. Joshi A, Narain JP, Prasittisuk C, Bhati R, Hashim G, et al. (2008) Can Visceral
Leishmaniasis be eliminated from Asia? J Vector Borne Diseases 45: 105–111.
3. Desjeux P (1996) Public Health aspects and control. Clin Dermatol 14: 417–423.
4. Bern C, Chowdhury R (2006) The epidemiology of visceral leishmaniasis in
Bangladesh: prospects for improved control. Indian J Med Res 123: 275–288.
5. Mondal D, Singh SP, Kumar N, Joshi AB, Sundar S, et al. (2009) Visceral
Leishmaniasis elimination programme in India, Bangladesh and Nepal:
reshaping the case findings/case management strategy. PLoS Negl Trop Dis
3(1): e355. Doi:10.1371/journal.pntd.0000355.
6. Hasker E, Singh SP, Malaviya P, Singh RP, Shankar R, et al. Management of
visceral leishmaniasis in rural primary health care services in Bihar, India. Trop
Med Int Health 15(Suppl 2): 55–62.
7. Thakur HP, Roy Burman JJ (2007) The problem of Kala Azar in Bihar and
West Bengal. J Indian Antrop Soc 42: 49–62.
8. Das P, Samuels S, Desjeux P, Mittal A, Topno R, et al. (2010) Annual incidence
of visceral leishmaniasis in an endemic area of Bihar, India. Trop Med Int
Health 15(Suppl 2): 4–11.
9. Rijal S, Uranw S, Chappuis F, Picado A, Khanal B, et al. (2010) Epidemiology
of Leishmania donovani infection in high transmission foci in Nepal. Trop Med
Int Health 15(Suppl 2): 21–28.
10. Singh VP, Ranjan A, Topno RK, Verma RB, Siddique NA, et al. (2010)
Estimation of under-reporting of visceral leishmaniasis cases in Bihar, India.
Am J Trop Med Hyg 82: 9–11.
11. Singh SP, Reddy DCS, Rai M, Sundar S (2006) Serious underreporting of VL
through passive case reporting in Bihar, India. Trop Med Int Health 11:
899–905.
12. Hirve SS, Singh SP, Kumar N, Banjara MR, Das P, et al. (2010) Effectiveness
and feasibility of active and passive case detection in the visceral leishmaniasis
elimination initiative in India, Bangladesh and Nepal. Am J Trop Med Hygiene
83: 507–511.
13. Frieden T, ed. Toman’s Tuberculosis: Case detection, treatment and
monitoring- questions and answers. 2nd edition. World Health Organization,
Geneva 2004. url: whqlibdoc.who.int/publications/2004/9241546034_1.pdf.
14. Bern C, Hightower AW, Chowdhury R, Ali M, Amann J, et al. (2005) Risk
factors for Kala-azar in Bangladesh. Emerg Infect Dis 11: 655–662.
15. Olliaro P, Darley S, Laxminaryan R, Sundar S (2009) Cost-effectiveness
projections of single and combination therapies for visceral leishmaniasis in
Bihar, India. Trop Med Int Health 14: 1–8.
16. Meheus F, Boelaert M, Baltussen R, Sundar S (2006) Costs of patient
management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med
Int Health 11: 1715–1724.
17. Rijal S, Koirala S, Van der Stuyft P, Boelaert M (2006) The economic burden of
visceral leishmaniasis for households in Nepal. Trans R Soc Trop Med Hyg 100:
838–841.
18. Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain S, et al. (2010) Enhanced
case detection of post Kala Azar dermal leishmaniasis (PKDL) by trained village
volunteers for early diagnosis, treatment and control of Kala Azar in
Bangladesh. PLoS Negl Trop Dis 4(10): e832. Doi:10.1371/journal.
pntd.0000832.
Case Detection Strategies for VL
www.plosntds.org 8 February 2011 | Volume 5 | Issue 2 | e960
